Form DRS - Draft Registration Statement:
SEC Accession No. 0001104659-25-072156
Filing Date
2025-07-30
Accepted
2025-07-30 16:06:38
Documents
4

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 657062
2 GRAPHIC fc_therapeuticspipe-4clr.jpg GRAPHIC 55385
3 GRAPHIC lg_dboralcapital-4clr.jpg GRAPHIC 18015
4 GRAPHIC lg_xortxtherapeutics-4clr.jpg GRAPHIC 26255
  Complete submission text file 0001104659-25-072156.txt   795782
Mailing Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5
Business Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5 403-607-2621
XORTX Therapeutics Inc. (Filer) CIK: 0001729214 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-08272 | Film No.: 251167039
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)